Performance analysis of Tonix Pharmaceuticals (TNXP)
Annual Return
Over the past 3 years, TNXP has had an average annual return of +0%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, TNXP has had an average annual return of +0%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, TNXP has had an average annual return of -75.33%, underperforming the benchmark SPY, which returned +14.95% annual.
Since May 10, 2012, TNXP has had an average annual return of -64.65%, underperforming the benchmark SPY, which returned +14.68% annual.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | +0% | -85.71% | -93.91% | -26.75% | -93.86% | +31.33% | -43.35% | -6.27% | -63.33% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +0% | +0% | +0% | ||||||||||
| 2020 | +0% | +0% | +0% | +0% | |||||||||
| 2019 | -14.29% | +0% | +33.33% | -12.50% | -14.29% | -16.67% | -60.00% | -50.00% | +0% | +0% | +0% | -85.71% | |
| 2018 | +3.48% | -1.68% | -14.53% | +4% | +9.62% | +29.82% | -73.65% | -7.69% | -44.44% | +20% | -29.17% | -58.82% | -93.91% |
| 2017 | +14.65% | -7.22% | -6.59% | -10.90% | +3.60% | -0% | -9.03% | -3.82% | +20.63% | -19.08% | +11.38% | -16.06% | -26.75% |
Drawdown analysis of Tonix Pharmaceuticals (TNXP)
The maximum drawdown for the TNXP was -99.99%, occurring on Aug 7, 2019. This drawdown has not yet recovered.
The current TNXP drawdown is -99.99%.
Since May 10, 2012 TNXP has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | May 10, 2012 | 1821 | Aug 7, 2019 | Ongoing | Ongoing | Ongoing |